| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 27 | 2022 | 359 | 5.550 |
Why?
|
| Macrophages | 25 | 2024 | 1324 | 3.110 |
Why?
|
| Lung | 41 | 2023 | 3664 | 2.690 |
Why?
|
| Acute Lung Injury | 10 | 2018 | 310 | 2.670 |
Why?
|
| Pneumonia | 16 | 2023 | 592 | 2.030 |
Why?
|
| Inflammation | 18 | 2023 | 2566 | 1.880 |
Why?
|
| Apoptosis | 23 | 2022 | 2484 | 1.860 |
Why?
|
| Phagocytosis | 16 | 2023 | 364 | 1.730 |
Why?
|
| Sequence Analysis, RNA | 6 | 2023 | 409 | 1.490 |
Why?
|
| Cigarette Smoking | 2 | 2022 | 85 | 1.450 |
Why?
|
| Pulmonary Alveoli | 6 | 2021 | 384 | 1.360 |
Why?
|
| Bleomycin | 6 | 2019 | 228 | 1.280 |
Why?
|
| Pulmonary Fibrosis | 6 | 2018 | 303 | 1.270 |
Why?
|
| Mice, Inbred C57BL | 37 | 2022 | 4908 | 1.270 |
Why?
|
| Mice | 60 | 2024 | 15520 | 1.170 |
Why?
|
| Myeloid Cells | 3 | 2019 | 128 | 1.150 |
Why?
|
| Animals | 77 | 2024 | 33381 | 1.110 |
Why?
|
| Lung Injury | 3 | 2015 | 210 | 1.090 |
Why?
|
| Pulmonary Emphysema | 2 | 2022 | 327 | 1.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 8 | 2022 | 613 | 0.960 |
Why?
|
| Phagocytes | 5 | 2020 | 91 | 0.960 |
Why?
|
| Mice, Transgenic | 18 | 2023 | 2025 | 0.940 |
Why?
|
| Dyspnea | 7 | 2015 | 201 | 0.880 |
Why?
|
| RNA Splicing | 3 | 2023 | 243 | 0.870 |
Why?
|
| Gene Expression Profiling | 7 | 2021 | 1597 | 0.870 |
Why?
|
| RNA Precursors | 2 | 2020 | 136 | 0.850 |
Why?
|
| Cytophagocytosis | 1 | 2022 | 10 | 0.840 |
Why?
|
| Monocytes | 8 | 2023 | 513 | 0.830 |
Why?
|
| Polyamines | 1 | 2022 | 39 | 0.830 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 6 | 2022 | 1137 | 0.800 |
Why?
|
| Lipopolysaccharides | 11 | 2023 | 870 | 0.790 |
Why?
|
| Lymph Nodes | 5 | 2020 | 455 | 0.790 |
Why?
|
| Mucins | 3 | 2018 | 59 | 0.730 |
Why?
|
| Disease Models, Animal | 13 | 2022 | 3730 | 0.710 |
Why?
|
| Superoxide Dismutase | 3 | 2019 | 339 | 0.680 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2021 | 509 | 0.660 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 702 | 0.660 |
Why?
|
| Epithelial Cells | 5 | 2018 | 963 | 0.640 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2018 | 21 | 0.640 |
Why?
|
| CD11 Antigens | 1 | 2018 | 32 | 0.630 |
Why?
|
| Flow Cytometry | 9 | 2022 | 1085 | 0.630 |
Why?
|
| Antigens, CD | 4 | 2017 | 460 | 0.620 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2017 | 43 | 0.620 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2023 | 1171 | 0.600 |
Why?
|
| CD11b Antigen | 2 | 2016 | 59 | 0.590 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2016 | 55 | 0.590 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2016 | 13 | 0.590 |
Why?
|
| Humans | 87 | 2024 | 118972 | 0.590 |
Why?
|
| Gene Deletion | 2 | 2018 | 361 | 0.580 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 62 | 0.580 |
Why?
|
| Diagnosis, Differential | 11 | 2016 | 1384 | 0.550 |
Why?
|
| Teratoma | 1 | 2016 | 92 | 0.550 |
Why?
|
| Inflammation Mediators | 5 | 2017 | 502 | 0.550 |
Why?
|
| Receptors, Immunologic | 4 | 2019 | 209 | 0.550 |
Why?
|
| Virus Diseases | 1 | 2018 | 198 | 0.530 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 229 | 0.530 |
Why?
|
| Male | 49 | 2022 | 57801 | 0.530 |
Why?
|
| Hypertension, Pulmonary | 7 | 2020 | 1794 | 0.520 |
Why?
|
| Mice, Knockout | 15 | 2022 | 2680 | 0.520 |
Why?
|
| Lung Diseases | 4 | 2022 | 718 | 0.510 |
Why?
|
| Fas Ligand Protein | 1 | 2014 | 60 | 0.490 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 2013 | 3 | 0.470 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 618 | 0.470 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2013 | 18 | 0.470 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2013 | 143 | 0.470 |
Why?
|
| Immune System Diseases | 1 | 2013 | 35 | 0.470 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2019 | 114 | 0.460 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 181 | 0.450 |
Why?
|
| Female | 41 | 2022 | 61564 | 0.440 |
Why?
|
| Regeneration | 1 | 2014 | 165 | 0.440 |
Why?
|
| Muscle Weakness | 1 | 2013 | 82 | 0.440 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 33 | 0.440 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2013 | 83 | 0.430 |
Why?
|
| fas Receptor | 2 | 2014 | 98 | 0.430 |
Why?
|
| Sepsis | 1 | 2018 | 531 | 0.420 |
Why?
|
| Bone Marrow Transplantation | 4 | 2015 | 244 | 0.420 |
Why?
|
| Cough | 4 | 2015 | 102 | 0.410 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 420 | 0.410 |
Why?
|
| Leukocytes | 3 | 2022 | 290 | 0.400 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 4 | 2022 | 451 | 0.390 |
Why?
|
| Hypoxia | 5 | 2022 | 963 | 0.390 |
Why?
|
| Signal Transduction | 12 | 2022 | 4709 | 0.390 |
Why?
|
| Zinc | 1 | 2013 | 262 | 0.380 |
Why?
|
| Healthy Volunteers | 2 | 2022 | 201 | 0.380 |
Why?
|
| Transforming Growth Factor beta | 5 | 2017 | 462 | 0.380 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 359 | 0.380 |
Why?
|
| Macrophage Activation | 3 | 2022 | 168 | 0.370 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2010 | 24 | 0.370 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 2674 | 0.360 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 72 | 0.360 |
Why?
|
| Gamma Rays | 1 | 2010 | 52 | 0.360 |
Why?
|
| Neutrophils | 7 | 2023 | 1233 | 0.360 |
Why?
|
| Mucociliary Clearance | 3 | 2018 | 43 | 0.350 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2020 | 95 | 0.350 |
Why?
|
| Thrombospondin 1 | 2 | 2020 | 22 | 0.350 |
Why?
|
| Podocytes | 2 | 2020 | 57 | 0.340 |
Why?
|
| Thyrotoxicosis | 1 | 2008 | 7 | 0.340 |
Why?
|
| Liver Failure, Acute | 1 | 2009 | 63 | 0.340 |
Why?
|
| Cells, Cultured | 16 | 2019 | 4077 | 0.330 |
Why?
|
| Antigens, Differentiation | 2 | 2008 | 79 | 0.330 |
Why?
|
| Herpes Simplex | 1 | 2009 | 90 | 0.330 |
Why?
|
| Lymphomatoid Granulomatosis | 1 | 2008 | 4 | 0.330 |
Why?
|
| Cytokines | 9 | 2023 | 1900 | 0.330 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2008 | 24 | 0.330 |
Why?
|
| Chest Pain | 1 | 2008 | 84 | 0.330 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2008 | 33 | 0.320 |
Why?
|
| Pharyngitis | 1 | 2008 | 25 | 0.320 |
Why?
|
| Mucin 5AC | 3 | 2016 | 46 | 0.300 |
Why?
|
| Respiratory Mucosa | 4 | 2018 | 254 | 0.300 |
Why?
|
| Alcoholism | 1 | 2013 | 717 | 0.290 |
Why?
|
| Interleukin-6 | 6 | 2023 | 688 | 0.290 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2023 | 119 | 0.290 |
Why?
|
| Cell Count | 2 | 2020 | 315 | 0.290 |
Why?
|
| Tracheitis | 1 | 2006 | 3 | 0.290 |
Why?
|
| Breeding | 2 | 2018 | 56 | 0.290 |
Why?
|
| Interleukin-13 | 2 | 2018 | 135 | 0.280 |
Why?
|
| Bronchitis | 1 | 2006 | 39 | 0.280 |
Why?
|
| Sleep Apnea, Central | 1 | 2005 | 10 | 0.280 |
Why?
|
| Dendritic Cells | 5 | 2020 | 442 | 0.270 |
Why?
|
| Jaundice | 1 | 2004 | 15 | 0.260 |
Why?
|
| Middle Aged | 17 | 2021 | 27617 | 0.260 |
Why?
|
| Methemoglobinemia | 1 | 2004 | 13 | 0.260 |
Why?
|
| Mucin-5B | 3 | 2016 | 175 | 0.260 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2004 | 15 | 0.260 |
Why?
|
| Pulmonary Artery | 2 | 2017 | 1063 | 0.250 |
Why?
|
| Influenza A virus | 2 | 2018 | 90 | 0.250 |
Why?
|
| Colitis, Ulcerative | 1 | 2006 | 105 | 0.250 |
Why?
|
| Intensive Care Units | 2 | 2013 | 635 | 0.250 |
Why?
|
| Hospitalists | 1 | 2008 | 173 | 0.250 |
Why?
|
| Vasoconstriction | 2 | 2020 | 213 | 0.250 |
Why?
|
| Adult | 17 | 2021 | 31512 | 0.250 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 2220 | 0.240 |
Why?
|
| Fibroblasts | 6 | 2017 | 842 | 0.240 |
Why?
|
| Bone Marrow Cells | 4 | 2017 | 273 | 0.240 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2016 | 61 | 0.240 |
Why?
|
| Critical Care | 1 | 2008 | 492 | 0.230 |
Why?
|
| Immunohistochemistry | 3 | 2020 | 1691 | 0.230 |
Why?
|
| Gene Expression | 3 | 2018 | 1489 | 0.230 |
Why?
|
| Folate Receptor 2 | 1 | 2023 | 7 | 0.230 |
Why?
|
| Scoliosis | 1 | 2005 | 183 | 0.230 |
Why?
|
| Mucus | 2 | 2021 | 54 | 0.220 |
Why?
|
| Killer Cells, Natural | 2 | 2023 | 381 | 0.220 |
Why?
|
| Calcinosis | 1 | 2005 | 282 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 6 | 2021 | 1206 | 0.220 |
Why?
|
| Critical Illness | 1 | 2008 | 662 | 0.220 |
Why?
|
| Shock, Septic | 2 | 2018 | 187 | 0.220 |
Why?
|
| X-Ray Microtomography | 1 | 2022 | 79 | 0.220 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 29 | 0.210 |
Why?
|
| Transcriptome | 2 | 2019 | 756 | 0.210 |
Why?
|
| Peripheral Tolerance | 1 | 2022 | 14 | 0.210 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2022 | 33 | 0.210 |
Why?
|
| Spermidine | 1 | 2022 | 12 | 0.210 |
Why?
|
| Vascular System Injuries | 1 | 2023 | 70 | 0.210 |
Why?
|
| Cellular Microenvironment | 2 | 2020 | 79 | 0.210 |
Why?
|
| Spermine | 1 | 2022 | 28 | 0.210 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 532 | 0.210 |
Why?
|
| Neuropeptides | 1 | 2022 | 68 | 0.210 |
Why?
|
| Cell Lineage | 3 | 2020 | 318 | 0.200 |
Why?
|
| Mycobacterium abscessus | 1 | 2023 | 97 | 0.200 |
Why?
|
| Extracellular Traps | 1 | 2021 | 40 | 0.200 |
Why?
|
| Cysts | 1 | 2022 | 93 | 0.200 |
Why?
|
| Sulfhydryl Compounds | 1 | 2023 | 179 | 0.200 |
Why?
|
| Endothelial Cells | 3 | 2022 | 732 | 0.200 |
Why?
|
| Immunomodulation | 1 | 2022 | 89 | 0.200 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2021 | 989 | 0.200 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2017 | 464 | 0.200 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2021 | 89 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 246 | 0.190 |
Why?
|
| Foreign Bodies | 1 | 2022 | 98 | 0.190 |
Why?
|
| Disulfides | 1 | 2021 | 91 | 0.190 |
Why?
|
| Steroid Hydroxylases | 1 | 2020 | 22 | 0.190 |
Why?
|
| Leukosialin | 1 | 2020 | 15 | 0.190 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 14 | 0.190 |
Why?
|
| Bronchi | 2 | 2015 | 242 | 0.190 |
Why?
|
| Optical Devices | 1 | 2020 | 12 | 0.190 |
Why?
|
| Perfusion | 1 | 2021 | 153 | 0.190 |
Why?
|
| Membrane Glycoproteins | 3 | 2019 | 446 | 0.190 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 63 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2017 | 2436 | 0.180 |
Why?
|
| MicroRNAs | 2 | 2017 | 637 | 0.180 |
Why?
|
| Pressure | 1 | 2021 | 226 | 0.180 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2019 | 165 | 0.180 |
Why?
|
| Oxidative Stress | 4 | 2020 | 1178 | 0.180 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 348 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 341 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 2 | 2018 | 180 | 0.180 |
Why?
|
| Kidney Failure, Chronic | 1 | 2005 | 516 | 0.180 |
Why?
|
| Sputum | 1 | 2021 | 290 | 0.180 |
Why?
|
| Implants, Experimental | 1 | 2019 | 19 | 0.180 |
Why?
|
| Extracellular Fluid | 1 | 2019 | 32 | 0.180 |
Why?
|
| Kidney Glomerulus | 1 | 2020 | 133 | 0.180 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2019 | 2 | 0.180 |
Why?
|
| Busulfan | 1 | 2019 | 14 | 0.180 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2019 | 15 | 0.170 |
Why?
|
| Vital Capacity | 3 | 2017 | 260 | 0.170 |
Why?
|
| Gene Targeting | 2 | 2018 | 80 | 0.170 |
Why?
|
| rho-Associated Kinases | 4 | 2020 | 84 | 0.170 |
Why?
|
| Lentivirus | 1 | 2019 | 52 | 0.170 |
Why?
|
| Blood Vessels | 1 | 2021 | 187 | 0.170 |
Why?
|
| Dasatinib | 1 | 2019 | 46 | 0.170 |
Why?
|
| Arginase | 1 | 2019 | 29 | 0.170 |
Why?
|
| Cholestenes | 1 | 2018 | 2 | 0.170 |
Why?
|
| Organ Specificity | 2 | 2017 | 278 | 0.170 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 2445 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 176 | 0.170 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 211 | 0.170 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2019 | 88 | 0.170 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 204 | 0.160 |
Why?
|
| Chemokine CCL11 | 1 | 2018 | 22 | 0.160 |
Why?
|
| Alpha-Globulins | 1 | 2018 | 21 | 0.160 |
Why?
|
| Actin Cytoskeleton | 1 | 2019 | 100 | 0.160 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2023 | 334 | 0.160 |
Why?
|
| Polyethylene Glycols | 2 | 2022 | 578 | 0.160 |
Why?
|
| Viral Plaque Assay | 1 | 2018 | 24 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 367 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2024 | 554 | 0.160 |
Why?
|
| Interferon-beta | 1 | 2018 | 82 | 0.160 |
Why?
|
| Transplantation Conditioning | 1 | 2019 | 156 | 0.160 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 42 | 0.160 |
Why?
|
| Genetic Vectors | 1 | 2019 | 302 | 0.160 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 75 | 0.160 |
Why?
|
| Tissue Donors | 1 | 2020 | 336 | 0.160 |
Why?
|
| Asthma | 5 | 2021 | 2158 | 0.150 |
Why?
|
| Schistosoma | 1 | 2017 | 18 | 0.150 |
Why?
|
| Genetic Therapy | 1 | 2019 | 267 | 0.150 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 1774 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2020 | 670 | 0.150 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 239 | 0.150 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2018 | 102 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2021 | 268 | 0.150 |
Why?
|
| RNA Virus Infections | 1 | 2017 | 11 | 0.150 |
Why?
|
| Myoclonus | 1 | 2016 | 11 | 0.150 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2018 | 61 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 984 | 0.150 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3171 | 0.150 |
Why?
|
| Integrases | 1 | 2018 | 123 | 0.150 |
Why?
|
| Aged | 9 | 2020 | 19657 | 0.150 |
Why?
|
| Recombination, Genetic | 1 | 2018 | 173 | 0.150 |
Why?
|
| 5'-Nucleotidase | 1 | 2017 | 34 | 0.150 |
Why?
|
| Hallucinations | 1 | 2016 | 29 | 0.150 |
Why?
|
| RNA Viruses | 1 | 2017 | 28 | 0.150 |
Why?
|
| Glycoproteins | 2 | 2021 | 319 | 0.150 |
Why?
|
| Endothelium | 2 | 2014 | 120 | 0.140 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2016 | 28 | 0.140 |
Why?
|
| Histones | 1 | 2021 | 552 | 0.140 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2016 | 117 | 0.140 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2016 | 14 | 0.140 |
Why?
|
| Hydrogels | 2 | 2022 | 582 | 0.140 |
Why?
|
| Reactive Oxygen Species | 3 | 2009 | 576 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 197 | 0.140 |
Why?
|
| Glycosylation | 1 | 2016 | 129 | 0.140 |
Why?
|
| Psychomotor Agitation | 1 | 2016 | 71 | 0.140 |
Why?
|
| Trachea | 2 | 2015 | 226 | 0.140 |
Why?
|
| Oxidants | 2 | 2007 | 122 | 0.140 |
Why?
|
| Viral Load | 1 | 2018 | 419 | 0.140 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 29 | 0.140 |
Why?
|
| Schistosomiasis mansoni | 1 | 2015 | 24 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 446 | 0.140 |
Why?
|
| Sex Factors | 1 | 2021 | 1781 | 0.130 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2012 | 79 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 4 | 2010 | 80 | 0.130 |
Why?
|
| Radiography | 3 | 2013 | 861 | 0.130 |
Why?
|
| Acute Kidney Injury | 3 | 2013 | 709 | 0.130 |
Why?
|
| Carmustine | 1 | 2015 | 47 | 0.130 |
Why?
|
| Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2014 | 5 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1308 | 0.130 |
Why?
|
| Interleukin-4 | 1 | 2015 | 215 | 0.130 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2015 | 95 | 0.130 |
Why?
|
| Mitochondria | 1 | 2020 | 786 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 3 | 2010 | 65 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2014 | 78 | 0.120 |
Why?
|
| Housing, Animal | 1 | 2014 | 46 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2016 | 227 | 0.120 |
Why?
|
| B-Lymphocytes | 4 | 2022 | 770 | 0.120 |
Why?
|
| AC133 Antigen | 1 | 2013 | 20 | 0.120 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2014 | 22 | 0.120 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2012 | 58 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 300 | 0.120 |
Why?
|
| Colony-Forming Units Assay | 1 | 2013 | 93 | 0.120 |
Why?
|
| Fibrosis | 3 | 2022 | 483 | 0.120 |
Why?
|
| Leukocyte Common Antigens | 1 | 2013 | 76 | 0.120 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 98 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 86 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2874 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 811 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1158 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 398 | 0.110 |
Why?
|
| Survivors | 2 | 2013 | 418 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 331 | 0.110 |
Why?
|
| Homeostasis | 1 | 2016 | 594 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 589 | 0.110 |
Why?
|
| Eosinophils | 1 | 2014 | 282 | 0.110 |
Why?
|
| Glycocalyx | 1 | 2012 | 23 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 36 | 0.110 |
Why?
|
| Metabolomics | 1 | 2017 | 550 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2012 | 527 | 0.110 |
Why?
|
| Genotype | 1 | 2018 | 1882 | 0.110 |
Why?
|
| Lymphatic Vessels | 1 | 2012 | 54 | 0.110 |
Why?
|
| Cell Movement | 1 | 2016 | 896 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2019 | 540 | 0.110 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 520 | 0.100 |
Why?
|
| Survival Analysis | 5 | 2017 | 1267 | 0.100 |
Why?
|
| Transplantation, Homologous | 2 | 2010 | 415 | 0.100 |
Why?
|
| NADPH Oxidases | 2 | 2009 | 138 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 67 | 0.100 |
Why?
|
| Caspase 8 | 1 | 2011 | 47 | 0.100 |
Why?
|
| Fatal Outcome | 2 | 2009 | 287 | 0.100 |
Why?
|
| Endotoxemia | 1 | 2012 | 93 | 0.100 |
Why?
|
| Leg | 1 | 2013 | 234 | 0.100 |
Why?
|
| Biopsy | 3 | 2012 | 1079 | 0.100 |
Why?
|
| Hypoalbuminemia | 1 | 2010 | 27 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 468 | 0.090 |
Why?
|
| Radiation Chimera | 1 | 2010 | 31 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2014 | 347 | 0.090 |
Why?
|
| Collagen | 1 | 2012 | 433 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2012 | 191 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2275 | 0.090 |
Why?
|
| Phosphodiesterase I | 1 | 2009 | 3 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 97 | 0.090 |
Why?
|
| Serotonin Antagonists | 1 | 2009 | 31 | 0.090 |
Why?
|
| Allergens | 2 | 2015 | 424 | 0.090 |
Why?
|
| Photophobia | 1 | 2009 | 10 | 0.090 |
Why?
|
| Interferon-gamma | 2 | 2010 | 736 | 0.090 |
Why?
|
| Herpes Labialis | 1 | 2009 | 8 | 0.090 |
Why?
|
| Pancreatic Elastase | 1 | 2009 | 74 | 0.090 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2009 | 59 | 0.090 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2009 | 36 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 610 | 0.090 |
Why?
|
| Herpesvirus 2, Human | 1 | 2009 | 28 | 0.090 |
Why?
|
| Time Factors | 4 | 2018 | 6412 | 0.090 |
Why?
|
| Liver Function Tests | 1 | 2009 | 107 | 0.090 |
Why?
|
| Transcription, Genetic | 4 | 2020 | 1323 | 0.090 |
Why?
|
| Communicable Diseases | 1 | 2011 | 132 | 0.080 |
Why?
|
| Phenotype | 4 | 2019 | 3003 | 0.080 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2008 | 36 | 0.080 |
Why?
|
| South Africa | 1 | 2009 | 163 | 0.080 |
Why?
|
| Triiodothyronine | 1 | 2008 | 43 | 0.080 |
Why?
|
| Prednisone | 2 | 2008 | 235 | 0.080 |
Why?
|
| Epoprostenol | 1 | 2009 | 132 | 0.080 |
Why?
|
| Vomiting | 1 | 2009 | 123 | 0.080 |
Why?
|
| RAW 264.7 Cells | 2 | 2020 | 42 | 0.080 |
Why?
|
| Adolescent | 4 | 2021 | 18480 | 0.080 |
Why?
|
| Thyroxine | 1 | 2008 | 63 | 0.080 |
Why?
|
| Risk Factors | 2 | 2021 | 9000 | 0.080 |
Why?
|
| Ischemia | 1 | 2011 | 374 | 0.080 |
Why?
|
| Travel | 1 | 2009 | 116 | 0.080 |
Why?
|
| Herpesvirus 1, Human | 1 | 2009 | 81 | 0.080 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2008 | 65 | 0.080 |
Why?
|
| Pneumocystis carinii | 1 | 2008 | 7 | 0.080 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2008 | 14 | 0.080 |
Why?
|
| Peptides | 1 | 2013 | 879 | 0.080 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2008 | 25 | 0.080 |
Why?
|
| Binding, Competitive | 1 | 2008 | 205 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1974 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2009 | 387 | 0.080 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2008 | 83 | 0.080 |
Why?
|
| Amides | 2 | 2023 | 86 | 0.080 |
Why?
|
| Tongue | 1 | 2008 | 73 | 0.080 |
Why?
|
| B7-1 Antigen | 1 | 2008 | 69 | 0.080 |
Why?
|
| Fever | 1 | 2009 | 283 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2006 | 292 | 0.080 |
Why?
|
| Ligands | 2 | 2023 | 567 | 0.080 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2008 | 40 | 0.080 |
Why?
|
| Pain | 1 | 2013 | 735 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 328 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2009 | 306 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 219 | 0.070 |
Why?
|
| Paragonimiasis | 1 | 2006 | 1 | 0.070 |
Why?
|
| Paragonimus | 1 | 2006 | 1 | 0.070 |
Why?
|
| Phospholipases A | 1 | 2007 | 101 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 827 | 0.070 |
Why?
|
| Acyl Coenzyme A | 1 | 2006 | 30 | 0.070 |
Why?
|
| Species Specificity | 2 | 2020 | 565 | 0.070 |
Why?
|
| Cancer Vaccines | 1 | 2008 | 139 | 0.070 |
Why?
|
| Smoking | 2 | 2017 | 1487 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 2006 | 47 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 2008 | 416 | 0.070 |
Why?
|
| Lovastatin | 1 | 2006 | 27 | 0.070 |
Why?
|
| Fluticasone | 1 | 2006 | 87 | 0.070 |
Why?
|
| Lymphocyte Count | 2 | 2019 | 136 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 407 | 0.070 |
Why?
|
| Calreticulin | 1 | 2005 | 24 | 0.070 |
Why?
|
| Androstadienes | 1 | 2006 | 94 | 0.070 |
Why?
|
| Ethanol | 1 | 2010 | 575 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 160 | 0.070 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 125 | 0.070 |
Why?
|
| Immunophenotyping | 3 | 2014 | 278 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 311 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2020 | 330 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2008 | 174 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2006 | 119 | 0.070 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 2017 | 58 | 0.070 |
Why?
|
| Quality of Life | 2 | 2013 | 2366 | 0.070 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2004 | 9 | 0.060 |
Why?
|
| Methemoglobin | 1 | 2004 | 22 | 0.060 |
Why?
|
| Cilia | 2 | 2018 | 160 | 0.060 |
Why?
|
| Methylene Blue | 1 | 2004 | 24 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2010 | 892 | 0.060 |
Why?
|
| Blood Cell Count | 1 | 2004 | 53 | 0.060 |
Why?
|
| Graft vs Host Disease | 1 | 2007 | 216 | 0.060 |
Why?
|
| Syndrome | 1 | 2005 | 344 | 0.060 |
Why?
|
| Headache | 1 | 2005 | 128 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 940 | 0.060 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2004 | 41 | 0.060 |
Why?
|
| Cell Separation | 2 | 2019 | 296 | 0.060 |
Why?
|
| Kidney | 1 | 2011 | 1353 | 0.060 |
Why?
|
| Spine | 1 | 2005 | 144 | 0.060 |
Why?
|
| Jurkat Cells | 3 | 2012 | 134 | 0.060 |
Why?
|
| Mice, Inbred ICR | 3 | 2009 | 111 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 233 | 0.060 |
Why?
|
| Fatigue | 1 | 2005 | 297 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2018 | 872 | 0.060 |
Why?
|
| Splicing Factor U2AF | 1 | 2023 | 16 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 334 | 0.060 |
Why?
|
| Zymosan | 1 | 2023 | 64 | 0.060 |
Why?
|
| Hemolysis | 1 | 2004 | 174 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 162 | 0.060 |
Why?
|
| Anemia | 1 | 2004 | 146 | 0.060 |
Why?
|
| Acrylates | 1 | 2023 | 47 | 0.060 |
Why?
|
| Cell Line | 3 | 2019 | 2707 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 2 | 2017 | 96 | 0.060 |
Why?
|
| Epithelium | 1 | 2024 | 305 | 0.060 |
Why?
|
| Echocardiography | 1 | 2005 | 556 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2023 | 154 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2023 | 137 | 0.060 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2022 | 32 | 0.060 |
Why?
|
| Receptors, KIR | 1 | 2023 | 89 | 0.060 |
Why?
|
| Immunoglobulin D | 1 | 2022 | 28 | 0.060 |
Why?
|
| Ceramides | 1 | 2023 | 104 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2004 | 326 | 0.050 |
Why?
|
| Th2 Cells | 2 | 2017 | 164 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 465 | 0.050 |
Why?
|
| Disease Progression | 1 | 2009 | 2490 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2023 | 300 | 0.050 |
Why?
|
| United States | 3 | 2019 | 12555 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1868 | 0.050 |
Why?
|
| Ovalbumin | 2 | 2015 | 165 | 0.050 |
Why?
|
| Smad2 Protein | 2 | 2015 | 39 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 310 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2009 | 847 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 151 | 0.050 |
Why?
|
| Brain | 1 | 2013 | 2490 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2020 | 710 | 0.050 |
Why?
|
| Fixatives | 1 | 2021 | 16 | 0.050 |
Why?
|
| Expectorants | 1 | 2021 | 24 | 0.050 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2023 | 206 | 0.050 |
Why?
|
| Parabiosis | 1 | 2020 | 12 | 0.050 |
Why?
|
| Thrombin | 1 | 2021 | 143 | 0.050 |
Why?
|
| Protein Binding | 2 | 2018 | 1975 | 0.050 |
Why?
|
| Antigens, CD1 | 1 | 2020 | 60 | 0.050 |
Why?
|
| Liver X Receptors | 1 | 2020 | 30 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 187 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2009 | 1200 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 200 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2017 | 208 | 0.050 |
Why?
|
| Mitochondrial Membranes | 1 | 2020 | 34 | 0.050 |
Why?
|
| Stromal Cells | 1 | 2000 | 102 | 0.050 |
Why?
|
| Transfection | 2 | 2015 | 888 | 0.050 |
Why?
|
| Endodeoxyribonucleases | 1 | 2020 | 60 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2023 | 572 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 2014 | 270 | 0.040 |
Why?
|
| Foreign-Body Reaction | 1 | 2019 | 23 | 0.040 |
Why?
|
| Alarmins | 1 | 2019 | 25 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 164 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2019 | 83 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2012 | 828 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2005 | 1636 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 3588 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 187 | 0.040 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2019 | 69 | 0.040 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2019 | 93 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 542 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 193 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2009 | 1753 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 175 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 1510 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2019 | 204 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2022 | 378 | 0.040 |
Why?
|
| RNA Transport | 1 | 2017 | 22 | 0.040 |
Why?
|
| Bone Marrow | 2 | 2008 | 255 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2019 | 253 | 0.040 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 290 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 155 | 0.040 |
Why?
|
| Antigens, Ly | 1 | 2017 | 45 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 87 | 0.040 |
Why?
|
| Chemokine CXCL2 | 1 | 2017 | 44 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2014 | 1067 | 0.040 |
Why?
|
| Models, Biological | 3 | 2013 | 1715 | 0.040 |
Why?
|
| Apyrase | 1 | 2017 | 13 | 0.040 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2017 | 32 | 0.040 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2017 | 21 | 0.040 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2017 | 41 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2017 | 40 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 649 | 0.040 |
Why?
|
| Autophagy | 1 | 2020 | 315 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2017 | 84 | 0.040 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2015 | 8 | 0.030 |
Why?
|
| Rheumatoid Factor | 1 | 2017 | 156 | 0.030 |
Why?
|
| Prognosis | 2 | 2017 | 3443 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2015 | 22 | 0.030 |
Why?
|
| Cell Communication | 1 | 2017 | 281 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2015 | 47 | 0.030 |
Why?
|
| Schistosoma mansoni | 1 | 2015 | 39 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 51 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2015 | 57 | 0.030 |
Why?
|
| Auscultation | 1 | 2015 | 2 | 0.030 |
Why?
|
| Mitotic Index | 1 | 2015 | 27 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2019 | 703 | 0.030 |
Why?
|
| Aspergillus oryzae | 1 | 2015 | 3 | 0.030 |
Why?
|
| Methacholine Chloride | 1 | 2015 | 48 | 0.030 |
Why?
|
| Mucin-4 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Adenosine | 1 | 2017 | 211 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 327 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2015 | 133 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2022 | 1335 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2014 | 22 | 0.030 |
Why?
|
| Interleukin-27 | 1 | 2014 | 12 | 0.030 |
Why?
|
| DNA | 1 | 2021 | 1388 | 0.030 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2014 | 31 | 0.030 |
Why?
|
| Poly I-C | 1 | 2014 | 55 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2014 | 35 | 0.030 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 7 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 2014 | 24 | 0.030 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2014 | 17 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 833 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 978 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 258 | 0.030 |
Why?
|
| Lung Compliance | 1 | 2014 | 49 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 39 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 1720 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 3174 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2015 | 164 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 152 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 53 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 139 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 453 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 369 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2017 | 325 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2020 | 1664 | 0.030 |
Why?
|
| Remission Induction | 1 | 2014 | 247 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2017 | 2657 | 0.030 |
Why?
|
| Ear, Middle | 1 | 2013 | 92 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 1 | 2013 | 59 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 982 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2014 | 191 | 0.030 |
Why?
|
| Total Lung Capacity | 1 | 2013 | 33 | 0.030 |
Why?
|
| Skin | 2 | 2008 | 657 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 232 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2012 | 9 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 770 | 0.030 |
Why?
|
| APACHE | 1 | 2013 | 61 | 0.030 |
Why?
|
| Lymphangiogenesis | 1 | 2012 | 23 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2012 | 16 | 0.030 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2012 | 17 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 317 | 0.030 |
Why?
|
| Mutation | 1 | 2023 | 3457 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 262 | 0.030 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2012 | 25 | 0.030 |
Why?
|
| Heparitin Sulfate | 1 | 2012 | 42 | 0.030 |
Why?
|
| Glucuronidase | 1 | 2012 | 48 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2012 | 1284 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2012 | 41 | 0.030 |
Why?
|
| Neurons | 1 | 2000 | 1345 | 0.030 |
Why?
|
| Endotoxins | 1 | 2013 | 234 | 0.030 |
Why?
|
| Doxycycline | 1 | 2012 | 60 | 0.030 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2012 | 49 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 156 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 175 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2013 | 227 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2062 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1440 | 0.030 |
Why?
|
| Creatinine | 1 | 2013 | 491 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1633 | 0.020 |
Why?
|
| Prostate | 1 | 2012 | 158 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2012 | 187 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 443 | 0.020 |
Why?
|
| Pyrroles | 1 | 2012 | 191 | 0.020 |
Why?
|
| Emphysema | 1 | 2012 | 123 | 0.020 |
Why?
|
| Karnofsky Performance Status | 1 | 2010 | 36 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2014 | 726 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1990 | 18 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 934 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2014 | 604 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 394 | 0.020 |
Why?
|
| Magnetics | 1 | 1990 | 38 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1293 | 0.020 |
Why?
|
| Streptococcaceae | 1 | 2009 | 2 | 0.020 |
Why?
|
| Indoles | 1 | 2012 | 316 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 161 | 0.020 |
Why?
|
| Pinocytosis | 1 | 2009 | 11 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 307 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2009 | 61 | 0.020 |
Why?
|
| Clinical Medicine | 1 | 2009 | 20 | 0.020 |
Why?
|
| CD11c Antigen | 1 | 2009 | 38 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1474 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1990 | 135 | 0.020 |
Why?
|
| Myositis | 1 | 2009 | 41 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 1047 | 0.020 |
Why?
|
| Proteomics | 1 | 2014 | 876 | 0.020 |
Why?
|
| Chimera | 1 | 2008 | 60 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1059 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2014 | 831 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2010 | 12978 | 0.020 |
Why?
|
| Lead | 1 | 2008 | 47 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2008 | 36 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2009 | 98 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2008 | 20 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 736 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 2008 | 21 | 0.020 |
Why?
|
| Thymoma | 1 | 2008 | 31 | 0.020 |
Why?
|
| Renal Artery | 1 | 2008 | 30 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2009 | 194 | 0.020 |
Why?
|
| Hemoptysis | 1 | 2008 | 39 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 6561 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1194 | 0.020 |
Why?
|
| Pneumothorax | 1 | 2008 | 48 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 2007 | 77 | 0.020 |
Why?
|
| NADPH Oxidase 2 | 1 | 2007 | 42 | 0.020 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2007 | 46 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2008 | 276 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2007 | 71 | 0.020 |
Why?
|
| Time | 1 | 2007 | 77 | 0.020 |
Why?
|
| Food Parasitology | 1 | 2006 | 4 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2007 | 122 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2007 | 92 | 0.020 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2006 | 11 | 0.020 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2006 | 14 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2007 | 126 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2007 | 103 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 365 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 341 | 0.020 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2006 | 11 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 440 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2006 | 40 | 0.020 |
Why?
|
| Protein Prenylation | 1 | 2006 | 20 | 0.020 |
Why?
|
| Complement C1q | 1 | 2006 | 38 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 1 | 2008 | 141 | 0.020 |
Why?
|
| CD36 Antigens | 1 | 2006 | 42 | 0.020 |
Why?
|
| Leukemia, Plasma Cell | 1 | 2006 | 5 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 2008 | 263 | 0.020 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2006 | 29 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2006 | 32 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 1990 | 336 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 200 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 9342 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2008 | 300 | 0.020 |
Why?
|
| Immunization | 1 | 2008 | 412 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 874 | 0.020 |
Why?
|
| Bacteremia | 1 | 2008 | 161 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2006 | 68 | 0.020 |
Why?
|
| CD47 Antigen | 1 | 2005 | 22 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2005 | 27 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 67 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 55 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1945 | 0.020 |
Why?
|
| Acute Disease | 1 | 2008 | 940 | 0.020 |
Why?
|
| Infant | 1 | 2019 | 8293 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 305 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2006 | 133 | 0.020 |
Why?
|
| Child | 2 | 2017 | 19129 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 145 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2011 | 745 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 220 | 0.020 |
Why?
|
| Heterozygote | 1 | 2005 | 262 | 0.020 |
Why?
|
| Eosinophilia | 1 | 2006 | 184 | 0.020 |
Why?
|
| RNA Interference | 1 | 2006 | 460 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 788 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 289 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2006 | 192 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 1223 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 4596 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 1094 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 627 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2008 | 545 | 0.010 |
Why?
|
| Antioxidants | 1 | 2007 | 564 | 0.010 |
Why?
|
| Weight Loss | 1 | 2008 | 655 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 5690 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 565 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 2851 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2000 | 8 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 43 | 0.010 |
Why?
|
| Mesencephalon | 1 | 2000 | 57 | 0.010 |
Why?
|
| Lymphokines | 1 | 2000 | 122 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2006 | 1055 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 173 | 0.010 |
Why?
|
| Fibronectins | 1 | 2000 | 114 | 0.010 |
Why?
|
| Tretinoin | 1 | 2000 | 116 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2000 | 117 | 0.010 |
Why?
|
| Liver | 1 | 2008 | 1816 | 0.010 |
Why?
|
| Neuroglia | 1 | 2000 | 157 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2000 | 127 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 5116 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 9491 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2006 | 964 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 10793 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 2478 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 5392 | 0.010 |
Why?
|
| Latex | 1 | 1990 | 12 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 182 | 0.010 |
Why?
|
| Microspheres | 1 | 1990 | 130 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1990 | 191 | 0.010 |
Why?
|
| Leukemia | 1 | 1990 | 208 | 0.000 |
Why?
|
| Neoplasms | 1 | 1990 | 2179 | 0.000 |
Why?
|